Open -Label Trial on the Effects of Memantine in Adults With Obsessive-Compulsive Disorder After a Single Ketamine Infusion
Phase of Trial: Phase II
Latest Information Update: 16 May 2017
At a glance
- Drugs Memantine (Primary)
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- 18 Apr 2016 Status changed from active, no longer recruiting to completed.
- 21 Aug 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 30 May 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.